This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.


Section I: Current Perspectives in the Treatment of Depression

Published: October 1, 2003

Article Abstract

Remission has become the goal of treatment in depression, not only in clinical trials but in clinical practice as well. Treatment must be sufficient in dosage and in duration and tailored to the needs of each patient in order to achieve remission. Patients who reach remission not only enjoy the obvious benefits of decreased disability and improved functioning in work, family, and social life, they also have a lower risk of relapse and disease progression. Long-term pharmacologic or psychosocial treatment can also prevent the recurrence of depression. Depression is twice as prevalent in women as in men. Clinical trial data in subpopulations of women are increasingly available, allowing for better treatment options for women with depression across the life cycle. In this educational activity, prominent psychiatrists discuss remission and relapse, as well as treatments specifically tailored for women.’ ‹

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Volume: 5

Quick Links: Depression (MDD)


Sign-up to stay
up-to-date today!


Already registered? Sign In

Original Research

Young-Adult Social Outcomes of Attention-Deficit/Hyperactivity Disorder

ADHD that persisted into young-adulthood was associated with poorer outcomes in terms of education, employment, and emotional...